Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Ebola virus disease – Democratic Republic of the Congo: Disease outbreak news, 23 December 2020 - Democratic Republic of the Congo - ReliefWeb
  Thu, 23 Jan 2020 20:00 GMT
• Democratic Republic of Congo: Ebola Virus Disease - External Situation Report 76 - Democratic Republic of the Congo - ReliefWeb
  Tue, 21 Jan 2020 20:57 GMT
• Three new Ebola cases confirmed as MSF warns of instability - CIDRAP
  Thu, 16 Jan 2020 23:00 GMT
• North Kivu Ebola Situation Report #25 - January 10, 2020 - Democratic Republic of the Congo - ReliefWeb
  Wed, 22 Jan 2020 17:33 GMT
• Gilead assessing Ebola drug as possible coronavirus treatment - Reuters
  Thu, 23 Jan 2020 18:52 GMT
• Boston hospital only center in New England designated to treat Ebola patients - WCVB Boston
  Wed, 22 Jan 2020 23:46 GMT
• An Ebola survival miracle - UNICEF
  Mon, 20 Jan 2020 22:40 GMT
• Ebola exists. A day at the heart of the epidemic in the Democratic Republic of Congo - LifeGate
  Mon, 20 Jan 2020 17:15 GMT
• Outbreaks of lethal diseases like Ebola and the Wuhan coronavirus happen regularly. The US government just cut funding for the hospitals that deal with them - Bulletin of the Atomic Scientists
  Wed, 22 Jan 2020 11:00 GMT
• Winning community trust in Ebola control - Democratic Republic of the Congo - ReliefWeb
  Thu, 23 Jan 2020 07:55 GMT
• What Will It Take To Finally End Congo's Ebola Outbreak In 2020? - NPR
  Thu, 09 Jan 2020 08:00 GMT
• The inside story of how scientists produced an Ebola vaccine - STAT - STAT
  Tue, 07 Jan 2020 08:00 GMT
• Cases traced to Mabalako still fueling DRC Ebola outbreak - CIDRAP
  Wed, 15 Jan 2020 22:04 GMT
• The Ebola Outbreak Response So Far - Contagionlive.com
  Thu, 02 Jan 2020 08:00 GMT
• DRC Ebola outbreaks: Crisis update - 13 January 2020 - Democratic Republic of the Congo - ReliefWeb
  Tue, 14 Jan 2020 08:00 GMT

• PRO/AH/EDR> Ebola update (03): cases, summary, vaccination, violence
  Wed, 15 Jan 2020 19:35:18 -0500
  Ebola -- Worldwide/Unknown
  

• Nurse-led implementation of ETAT+ is associated with reduced mortality in a children's hospital in Freetown, Sierra Leone.
  
• Nonclinical safety assessment of repeated administration and biodistribution of ChAd3-EBO-Z Ebola candidate vaccine.
  
• IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
  
• Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.
  
• The cost of insecurity: from flare-up to control of a major Ebola virus disease hotspot during the outbreak in the Democratic Republic of the Congo, 2019.
  
• Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment.